Medicare Enrolled

Jonathan Garcellano, FNP-C

Q: Does Garcellano receive payments from pharmaceutical companies?

Yes. Garcellano received a total of $2,429 from 20 companies across 27 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Garcellano) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Nurse Practitioner - Family · Missouri City, TX

5947 TURKEY CRK, Missouri City, TX 77459

8328771954

Registered in NPPES since 2021

NPI: 1659955433 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Garcellano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Garcellano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Garcellano

Jonathan Garcellano is a nurse practitioner - family in Missouri City, TX, with 5 years of NPI registration.

Between the years covered by Open Payments, Garcellano received a total of $2,429 from 20 pharmaceutical and/or device companies across 27 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Garcellano is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years of NPI registration $2,429 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$2,429

Total received (2021-2024)

Avg $607/year across 4 years

Top 13% in TX for nurse practitioner - family

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$260

2023

$906

2022

$1,029

2021

$234

Payments by company (2024)

Xeris Pharmaceuticals, Inc.

$122

Gilead Sciences, Inc.

$104

ABBVIE INC.

$34

Top 3 companies account for 100.0% of 2024 payments

All-time payments by company (2021-2024) ›

GENZYME CORPORATION

$232

AstraZeneca Pharmaceuticals LP

$229

Alexion Pharmaceuticals, Inc.

$220

Werfen USA LLC

$207

ABBVIE INC.

$152

Xeris Pharmaceuticals, Inc.

$122

Stemline Therapeutics Inc.

$122

Inspire Medical Systems, Inc.

$119

Ultragenyx Pharmaceutical Inc.

$106

Gilead Sciences, Inc.

$104

Edwards Lifesciences Corporation

$101

GlaxoSmithKline, LLC.

$99

IDORSIA PHARMACEUTICALS US INC

$96

Teva Pharmaceuticals USA, Inc.

$95

Mylan Specialty L.P.

$94

Eli Lilly and Company

$93

SCYNEXIS, Inc.

$87

SK Life Science, Inc.

$61

Coloplast Corp

$54

Medtronic, Inc.

$38

Top 3 companies account for 28.0% of all-time payments

Associated products mentioned in payments ›

AJOVY · Altis · Crysvita · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · FABRAZYME · FASENRA · GVOKE HYPOPEN · INSPIRE · INTELLIS ADAPTIVESTIM · QUVIVIQ · SAPHNELO · SHINGRIX · Titan · UBRELVY · VRAYLAR · Vemlidy · XCOPRI · Yupelri

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a nurse practitioner - family in Missouri City?
Compare family nurse practitioners in the Missouri City area by procedure volume, costs, and industry payment transparency.

Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas

2,828

County median income

$113,409

Nearest hospital to ZIP centroid (approximate)

HOUSTON METHODIST SUGARLAND HOSPITAL
6.6 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Garcellano is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Garcellano receive payments from pharmaceutical companies?

Yes. Garcellano received a total of $2,429 from 20 companies across 27 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Garcellano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Family Nurse Practitioners in Missouri City

Browse family nurse practitioners in Missouri City ranked by procedure volume and transparency data.

Highest volume

Top Family Nurse Practitioners in TX

Family nurse practitioners ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Family Nurse Practitioners in TX

Which TX family nurse practitioners receive the most from drug and device companies.

By company

GENZYME CORPORATION Payments to Doctors

See all physicians who received payments from GENZYME CORPORATION.

By company

AstraZeneca Pharmaceuticals LP Payments to Doctors

See all physicians who received payments from AstraZeneca Pharmaceuticals LP.

By company

Alexion Pharmaceuticals, Inc. Payments to Doctors

See all physicians who received payments from Alexion Pharmaceuticals, Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology